The divergence between passive accumulation and active manager selling suggests the stock may be experiencing index-driven inflows rather than fundamental conviction. Monitor upcoming pipeline catalysts (clinical trial data) to see if active managers re-engage or continue reducing exposure.
Executive Summary
In Q2 2026, 15 institutional buyers accumulated $43.1M in PALI shares while 9 sellers reduced by $13.2M, resulting in a net inflow of ~$29.9M. The buying was dominated by mega-passive funds (BlackRock, Geode, Northern Trust) and quant fund Point72, which more than doubled its position to $11.0M. Sellers included major banks (Morgan Stanley, Goldman Sachs) and hedge funds (Marshall Wace, Millennium) trimming or nearly exiting. The mixed net direction suggests divergent views on Palisade Bio's pipeline prospects, with passive rebalancing likely driving much of the buying.
Key Financial Metrics
Institutional Positions
Net institutional flow: $29.9M
▲ Buyers (15)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BlackRock | DOUBLED | +456.2% | $21.8M | $18.5M |
| Point72 | DOUBLED | +1175.8% | $11.0M | $10.3M |
| Geode | DOUBLED | +143.2% | $7.9M | $5.2M |
| Wellington Management Group | ADD | +27.5% | $7.7M | $2.7M |
| Aberdeen Group | DOUBLED | +188.2% | $4.0M | $2.8M |
▼ Sellers (9)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Marshall Wace | NEAR_EXIT | -85.5% | $4.8M | -$4.0M |
| Morgan Stanley | TRIM | -45.6% | $8.0M | -$2.8M |
| Goldman Sachs | TRIM | -33.4% | $9.4M | -$1.9M |
| Balyasny Asset Management | TRIM | -42.7% | $5.7M | -$1.8M |
| Millennium | TRIM | -55.6% | $3.7M | -$1.7M |
Key Facts
- 15 buyers accumulated $43.1M in new holdings vs 9 sellers reducing by $13.2M
- BlackRock doubled its position to $21.8M (largest buyer by value)
- Point72 increased its stake by 1,175.8% to $11.0M
- Marshall Wace nearly exited, cutting 85.5% of its position from $4.8M to $833K
- Mega-passive funds (BlackRock, Geode, Northern Trust) accounted for the majority of buying
- Active managers showed mixed conviction: Wellington added $2.7M, while Balyasny and Millennium trimmed significantly
Financial Impact
Net institutional inflow of approximately $29.9M in Q2 2026, with total buyer holdings at $56.9M and seller reductions of $13.2M
Risk Factors
- 13F data is 45 days stale; positions may have already been adjusted
- Passive buying may not reflect fundamental conviction — could reverse on index rebalancing
- Active manager selling by Marshall Wace, Balyasny, and Millennium suggests skepticism on near-term catalysts
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-PALI-2026-Q2 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Institutional Cluster | $1.69 $1.43 | ▼ −15.38% | ▼ −14.82% | — |
Sep 22, 2026 5w ago | Press Release | $1.69 $1.43 | ▼ −15.38% | ▼ −14.82% | — |
Aug 10, 2026 11w ago | 8-K | $2.14 $2.05 | ▼ −4.21% | ▼ −3.15% | — |
Jul 10, 2026 15w ago | Insider Cluster | $1.89 $2.10 | ▲ +11.11% | ▲ +7.93% | — |
Jul 8, 2026 15w ago | Insider Cluster | $1.97 $2.09 | ▲ +6.09% | ▲ +3.85% | — |
Jun 11, 2026 19w ago | 8-K | $1.71 $1.96 | ▲ +14.62% | ▲ +12.84% | — |
May 22, 2026 22w ago | EFFECT | $1.95 $1.89 | ▼ −3.08% | ▼ −1.66% | — |
May 12, 2026 23w ago | S-3 | $1.87 $1.78 | ▼ −4.81% | ▼ −4.20% | — |
Apr 29, 2026 25w ago | DEFA14A | $2.00 $2.12 | ▲ +6.00% | ▲ +0.77% | — |
Apr 2, 2026 29w ago | 8-K | $1.89 $2.00 | ▲ +5.82% | ▼ −4.06% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers